期刊文献+

β-羟基丁酸对人星形胶质细胞瘤U251细胞增殖及PLD1表达的影响

Effect of BHB on proliferation and PLD1 expression of human astroglioma U251 cells
下载PDF
导出
摘要 目的探讨不同浓度β-羟基丁酸(beta-hydroxybutyrate,BHB)对人星形胶质瘤U251细胞增殖及磷脂酶D1(phospholipase D1,PLD1)表达的影响。方法体外培养人星形胶质瘤U251细胞,用0、2 mmol/L、4 mmol/L、8 mmol/L、10 mmol/L BHB处理24 h,采用MTT法检测各组细胞的活力;用Western blot实验检测各组细胞的PLD1蛋白表达水平。结果2 mmol/L、4 mmol/L、8 mmol/L、10 mmol/L BHB组U251细胞的活力均被明显抑制(均P<0.05),并随着BHB浓度的增高,细胞活力抑制越明显。2 mmol/L、4 mmol/L、8 mmol/L、10 mmol/L BHB组U251细胞的PLD1蛋白表达水平均明显下降(均P<0.05),并随着BHB浓度的增高,PLD1蛋白表达水平逐渐下降。结论BHB具有抑制人星形胶质瘤U251细胞增殖的作用,其机制可能与下调PLD1表达有关。 Objective To investigate the effects of different concentrations of beta-hydroxybutyrate(BHB)on its proliferation and phospholipase D1(PLD1)expression of human astroglioma cell line U251.Methods Primary cultured human astroglioma U251 cells were pretreated with BHB at various concentrations(2 mM,4 mM,8 mM and 10 mM)for 24 hours.The cell viability was detected by MTT assay.The expression of PLD1 protein was detected by Western blot.Results BHB concentrations of 2 mM,4 mM,8 mM and 10 mM could significantly inhibit the activity of U251 cells(P<0.05),the inhibition of cell activity was more obvious with the increase of BHB concentration.BHB concentrations of 2 mM,4 mM,8mM and 10 mM could significantly inhibit PLD1 protein expression level of U251 cells(P<0.05),and decrease with the increase of BHB concentration.Conclusion BHB can inhibit the proliferation of glioma U251,and its mechanism may be related to the down-regulation of PLD1 expression.
作者 廖泉 刘小飞 廖凌骁 周敏 陈雨晴 廖勇仕 LIAO Quan;LIU Xiao-fei;LIAO Ling-xiao(Second Affiliated Hospital of South China University, Hengyang 421001, China)
出处 《临床神经外科杂志》 CAS 2020年第6期630-633,共4页 Journal of Clinical Neurosurgery
基金 湖南省自然科学基金面上项目(2018JJ2353)。
关键词 β-羟基丁酸 磷脂酶1 胶质瘤 肿瘤增殖 beta-hydroxybutyrate PLD1 glioma tumor proliferation
  • 相关文献

参考文献2

二级参考文献19

  • 1石汉平.肿瘤新疗法-代谢调节治疗[J].肿瘤代谢与营养电子杂志.2014,1(1):3-5.
  • 2Wilder RM. The effect of ketonemia on the course of epilepsy.Mayo Clin Bulletin. 1921;2:307-308.
  • 3Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss andtumour size in a cachexia model by a high fat diet. Br J Cancer.1987;56(1):39-43.
  • 4Allen BG, Bhatia SK, Buatti JM, et al. Ketogenic diets enhanceoxidative stress and radio-chemo-therapy responses in lung cancerxenografts. Clin Cancer Res. 2013;19(14):3905-3913.
  • 5Klement RJ, Sweeney RA. Impact of a ketogenic diet interventionduring radiotherapy on body composition: I. Initial clinicalexperience with six prospectively studied patients. BMC Res Notes.2016;9(1):143.
  • 6Zuccoli G, Marcello N, Pisanello A, et al. Metabolic managementof glioblastoma multiforme using standard therapy together witha restricted ketogenic diet: Case Report. NutrMetab (Lond).2010,7:33.
  • 7Mavropoulos JC, Buschemeyer WC 3rd, Tewari AK, et al. Theeffects of varying dietary carbohydrate and fat content on survivalin a murine LNCaP prostate cancer xenograft model. Cancer PrevRes (Phila). 2009;2(6):557-565.
  • 8Beck SA, Tisdale MJ. Nitrogen excretion in cancer cachexia and itsmodification by a high fat diet in mice. Cancer Res. 1989;49(14):3800-3804.
  • 9Schmidt M, Pfetzer N, Schwab M, et al. Effects of a ketogenic dieton the quality of life in 16 patients with advanced cancer: A pilottrial. NutrMetab (Lond). 2011;8(1):54.
  • 10Kossoff EH, Hartman AL. Ketogenic diets: new advances formetabolism-based therapies.CurrOpin Neurol. 2012;25(2):173-178.

共引文献323

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部